Mirae Asset Global Investments’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29K Sell
844
-135
-14% -$3.97K ﹤0.01% 1442
2026
Q1
$30.3K Buy
979
+70
+8% +$1.72K ﹤0.01% 1378
2025
Q4
$19K Buy
909
+186
+26% +$3.46K ﹤0.01% 1542
2025
Q3
$11.3K Buy
723
+2
+0.3% +$41 ﹤0.01% 1563
2025
Q2
$14.3K Buy
721
+221
+44% +$4.48K ﹤0.01% 1443
2025
Q1
$9.32K Buy
500
+8
+2% +$261 ﹤0.01% 1475
2024
Q4
$23.1K Buy
+492
New +$20.8K ﹤0.01% 1402

Other funds holding TECX

Mirae Asset Global Investments's TECX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Tectonic Therapeutic (TECX) stake by 14% in Q2 2026, selling an estimated $3.97K and leaving 844 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Mirae Asset Global Investments first reported a position in TECX in Q4 2024 and has held it in 7 quarters since. The position peaked at $30.3K in Q1 2026. 14 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Mirae Asset Global Investments held 844 shares of Tectonic Therapeutic worth $29K as of Q2 2026.
  • Mirae Asset Global Investments sold 135 Tectonic Therapeutic shares in Q2 2026, an estimated $3.97K.
  • Tectonic Therapeutic made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1442 holding.
  • Mirae Asset Global Investments first reported a position in Tectonic Therapeutic in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Tectonic Therapeutic position peaked at $30.3K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.